Jan 7, 2026 07:33AM
Jan 7, 2026 07:30AM
Dec 15, 2025 07:02AM
Dec 15, 2025 07:00AM
Nov 10, 2025 04:02PM
Sep 3, 2025 06:52AM
Sep 2, 2025 07:00AM FibroGen completes $220 million sale of China unit to AstraZeneca
Sep 2, 2025 07:00AM
Aug 11, 2025 04:02PM
Aug 7, 2025 07:00AM
Aug 7, 2025 07:00AM
May 12, 2025 04:02PM
Mar 17, 2025 04:05PM
Feb 20, 2025 06:33AM FibroGen (FGEN) Sells FibroGen China to AstraZeneca (AZN) for $160M
Feb 20, 2025 06:30AM
Jul 30, 2024 04:05PM
Jun 3, 2024 04:05PM
Jun 3, 2024 04:05PM
Jun 3, 2024 04:02PM
Jun 3, 2024 04:02PM
May 23, 2024 05:05PM FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (m
May 6, 2024 04:02PM
Apr 3, 2024 05:43AM
Apr 2, 2024 05:46PM
Feb 26, 2024 04:06PM
Feb 5, 2024 07:00AM
Jan 25, 2024 07:07AM
Jan 25, 2024 07:00AM FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer
Nov 6, 2023 04:01PM
Aug 29, 2023 04:15PM
Aug 7, 2023 04:01PM
Jun 26, 2023 07:04AM
Jun 26, 2023 07:04AM
Jun 7, 2023 06:56AM
Jun 7, 2023 06:55AM FibroGen Announces Topline Results from LELANTOS-1 Phase 3 Clinical Study of Pamrevlumab in Non-Ambulatory Patients with Duchenne Muscular Dystrophy
May 8, 2023 04:01PM
Apr 3, 2023 07:00AM
Feb 27, 2023 04:01PM
Nov 7, 2022 04:01PM
Aug 8, 2022 04:01PM
Jun 8, 2022 07:00AM
Apr 20, 2022 07:00AM FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
Nov 9, 2021 04:01PM
Aug 11, 2021 03:27PM
Aug 11, 2021 09:46AM
Aug 11, 2021 07:00AM
Aug 11, 2021 07:00AM
Aug 9, 2021 04:01PM
Jul 16, 2021 11:34AM What Negative Roxadustat FDA AdCom Vote Means for Fibrogen's (FGEN) Stock?
Jul 16, 2021 09:30AM

322,898 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All